Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome

doi:10.3748/wjg.v28.i7.732

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 7

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11249)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

454

WORD

149

HTML

6517

Figures (1-7)

491

Tables (1-2)

561

Sum=8172

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

318

Download

635

Sum=953

Publishing Process of This Article

Item

Count

Browse

478

Download

1646

Sum=2124

Feb 21, 2022 (publication date) through Nov 2, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Feb 21, 2022; 28(7): 732-744
Published online Feb 21, 2022. doi: 10.3748/wjg.v28.i7.732

Table 1 Baseline characteristics of the study participants (mean ± SD)

Characteristic	IBS group, n = 233
Median age (IQR), yr	51.0 (37–66)
Female sex, n (%)	166 (71.2)
BMI (kg/m²)	24.5 ± 4.3
IBS sub-types (transit pattern), n (%)
IBS-C	71 (30.5)
IBS-D	89 (38.2)
IBS-M	61 (26.2)
IBS-U	12 (5.2)
IBS severity categories (IBS-SSS), n (%)
Remission (0–74)	2 (0.8)
Mild (75–174)	11 (4.7)
Moderate (175–299)	112 (48.1)
Severe (> 300)	108 (46.4)
IBS-QOL (0–100)	60.2 ± 20.5

BMI: Body mass index; C: Constipation; D: Diarrhea; IBS: Irritable bowel syndrome; IBS-QOL: Irritable bowel syndrome quality of life; IBS-SSS: Irritable bowel syndrome severity scoring system; IQR: Interquartile range; M: Mixed; U: Unclassified.

Citation: Sabaté JM, Iglicki F. Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome. World J Gastroenterol 2022; 28(7): 732-744
URL: https://www.wjgnet.com/1007-9327/full/v28/i7/732.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i7.732